1.
Safety of Estrogen-Based Feminizing Gender-Affirming Hormone Therapy:  A Practical Endocrine Approach to Risk Stratification and Monitoring. Can Diabetes Endocrinol Today [Internet]. 25 mai 2026 [cité 26 mai 2026];4(1):10–16. Disponible à: https://CanadianDiabetesAndEndocrinologyToday.com/article/view/4-1-Kissock